FDA Grants Breakthrough Therapy Designation to Novartis’ Ianalumab for Sjögren’s Disease
The FDA has granted Breakthrough Therapy designation to Novartis’ ianalumab for Sjögren’s…
The SFDA CEO Receives Syrian Minister of Health to Discuss Joint Cooperation
H.E. the CEO of the Saudi Food and Drug Authority (SFDA), Dr.…
Lilly to acquire Verve Therapeutics to advance one-time treatments for people with high cardiovascular risk
Eli Lilly and Company and Verve Therapeutics, Inc., a Boston-based clinical-stage company…
FDA grants accelerated approval to Novartis’ Vanrafia® for IgA Nephropathy treatment
Basel- April 2025- Novartis announced the US Food and Drug Administration (FDA)…
Hera Health Solutions wins Arab Health’s Innov8 competition, securing US$10,000 top prize
Dubai, United Arab Emirates- 30 January 2025: Hera Health Solutions has won…
Massimiliano Colella Named CEO of CMR Surgical
January 2025- CMR Surgical, the global surgical robotics business, announces the appointment…
FDA approves Bristol Myers Squibb’s Subcutaneous Opdivo Qvantig™ for various solid tumor indications
December 2024- Bristol Myers Squibb announced that the U.S. Food and Drug…
Gene Therapy for Children: A Conversation with Prof. Stephan Grupp | Dr. Zainul Aabideen | EPBMT2024
In this insightful interview, Dr. Zainul Aabideen speaks with Prof. Stephan Grupp,…
Abbott Unveils World-First Leadless Pacing in Heart’s Left Bundle
ABBOTT PARK, Ill., December 2024 - Abbott (NYSE: ABT) announced the successful completion…
How AI is revolutionising diagnosis and treatment
Artificial intelligence (AI) is rapidly transforming the medical landscape, revolutionising how diseases…
